Crispr Therapeutics Ag
CRSP
Revenue
517.00k
▲13.00k▲2.58%
3 Months ChangeAssets
2.34B
▼-99.16M▼-4.07%
3 Months ChangeLiabilities
358.90M
▲3.82M▲1.08%
3 Months ChangeFree Cash Flow
109.03M
▲103.29M▲1799.49%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-05
Form 10-Q
ID: 0000950170-24-090746
2024-08-05
Form 8-K
ID: 0000950170-24-090727
2024-06-03
Form 8-K
ID: 0000950170-24-067660
2024-05-23
Form 8-K
ID: 0000950123-24-005877
2024-05-08
Form 10-Q
ID: 0000950170-24-055719
2024-05-08
Form 8-K
ID: 0000950170-24-055689
2024-02-21
Form 8-K
ID: 0000950170-24-017568
2024-02-13
Form 8-K
ID: 0001193125-24-033973
2024-02-13
Form 8-K
ID: 0001193125-24-032825
2024-01-16
Form 8-K
ID: 0000950170-24-004616